Huifang Zong
Shanghai Jiao Tong University(CN)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, SARS-CoV-2 and COVID-19 Research, CAR-T cell therapy research, Glycosylation and Glycoproteins Research, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system(2017)69 cited
- → A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer(2020)61 cited
- → Production process reproducibility and product quality consistency of transient gene expression in HEK293 cells with anti-PD1 antibody as the model protein(2016)35 cited
- → Producing defucosylated antibodies with enhanced in vitro antibody‐dependent cellular cytotoxicity via FUT8 knockout CHO‐S cells(2017)28 cited
- → A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer(2024)27 cited
- → Enhanced production of anti-PD1 antibody in CHO cells through transient co-transfection with anti-apoptotic genes Bcl-x L and Mcl-1(2018)25 cited
- → Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies(2018)24 cited
- → Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD(2022)24 cited
- → A Rational Designed Novel Bispecific Antibody for the Treatment of GBM(2021)24 cited
- → Bioprocess development of a stable FUT8−/−-CHO cell line to produce defucosylated anti-HER2 antibody(2019)20 cited